Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss IndustryThe Motley Fool • 12/21/23
Compugen will be Eligible to Receive $10 Million Milestone Payment upon Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract CancerPRNewsWire • 12/19/23
Two Phase 3 Trials of Datopotamab Deruxtecan Plus Durvalumab Initiated in Patients Across Two Breast Cancer SubtypesBusiness Wire • 12/18/23
AstraZeneca will pay up to $1.1B to acquire Icosavax, a Univ. of Washington biotech spinoutGeekWire • 12/12/23
Icosavax surges 45% in pre-market trading as AstraZeneca agrees takeoverProactive Investors • 12/12/23
AstraZeneca Just Joined the AI Drug Development Craze, but Is It a Buy in 2024?The Motley Fool • 12/10/23
Dividend Lovers Betting Big on 6 Goldman Sachs Top Conviction List Picks for 202424/7 Wall Street • 12/09/23
AstraZeneca, Diageo, Lloyds & other UK Banks: What London's brokers had to say todayProactive Investors • 12/06/23
AstraZeneca and Novo Nordisk among the top picks of this top US bank - here's whyProactive Investors • 12/05/23